Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 7/15/2025Sino Biopharma Acquires Merck's Chinese Partner LaNova Medicines in $9...
  • 7/15/2025Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
  • 7/14/2025Eisai Launches Urece (Dotinurad) in China
  • 7/14/2025China 2024 Healthcare Insurance Report: Milestones in Coverage, Spendi...
  • 7/14/2025Shanghai Cell Therapy Unveils BZE2204: Rapid CAR‑T with Impressive Ef...
  • 7/14/2025Akeso Launches Phase II Study Combining BsAbs with Tinengotinib
  • 7/14/2025InnoCare Announces FDA Approval of Clinical Trial for BCL2 Inhibitor M...
  • 7/14/2025China Biopharma Financing Falls in H1 2025 Amid Fewer Mega-Rounds, IPO...
  • 7/14/2025GAH and Innostellar Launch 10-Year Alliance for LX-101 Gene Therapy in...
  • 7/14/2025Ascentage's Lisaftoclax (APG‑2575) Gains NMPA Green Light for CLL/SLL
  • 7/12/2025​​​​​​​Recent Official and Executive Moves
  • 7/12/2025China's First 9-Valent HPV Vaccine Launches at 60% Discount, Undercutt...
  • 7/12/2025Flamma Opens New cGMP Plant in Dalian
  • 7/11/2025Vice Premier Urges Stronger Focus on Basic Pharmaceutical Research an...
  • 7/11/2025Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches First Phase III T...
  • 7/11/2025Regenelead's KRAS-Targeted Cancer Vaccine Approved for Clinical Trials...
  • 7/11/2025Biocytogen Strengthens Ties with BeOne Thru Expanded Antibody Licensin...
  • 7/11/2025TandemAI and Perpetual Medicine Announce Strategic Merger
  • 7/11/2025Haleon Secures Full Ownership of Tianjin Sino‑American JV
  • 7/11/2025BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
  • 7/11/2025China's NHSA Unveils 2025 Drug Directory Revisions and Submission Guid...
  • 7/11/2025China Issues 2nd Batch of Rare Disease Clinical Guidelines to Strength...
  • 7/10/2025Henlius Wins Global Regulatory Clearance to Launch Phase 2 Trial of PD...
  • 7/10/2025China Approves Three New Drugs for Cancer, ED and Pediatric Sleep Diso...
  • 7/10/2025Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery...
  • 7/10/2025China's Biopharma Licensing Deals Surge in H1 2025, Fueled by Cross-Bo...
  • 7/9/2025Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
  • 7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
  • 7/9/2025Hansoh Pharma Launches Phase 1 Trial of HS-20093 with Adebrelimab in F...
  • 7/9/2025NKCellTech Secures Nearly CNY100M in Series A+++ Financing
  • Page:3/54 Total number of articles:1606: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group